Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as Therapy

Stable Gastric Pentadecapeptide BPC 157 May Recover Brain–Gut Axis and Gut–Brain Axis Function

(2023) Predrag Sikiric et al.   Pharmaceuticals

Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats

(2022) Ivan Barisic et al.   Biomedicines

Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma

(2022) Tamara Kralj et al.   Biomedicines

Therapy Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute Pancreatitis as Vascular Failure-Induced Severe Peripheral and Central Syndrome in Rats

(2022) Ivan Maria Smoday et al.   Biomedicines

Fatal pulmonary embolism in patients on antipsychotics: case series, systematic review and meta-analysis

(2022) Syrine Azza Manoubi et al.   Asian Journal of Psychiatry

BPC 157, L-NAME, L-Arginine, NO-Relation, in the Suited Rat Ketamine Models Resembling “Negative-Like” Symptoms of Schizophrenia

(2022) Andrea Zemba Cilic et al.   Biomedicines

Stable gastric pentadecapeptide BPC 157: prompt particular activation of the collateral pathways

(2022) Predrag Sikiric et al.   CURRENT MEDICINAL CHEMISTRY

Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation

(2022) Predrag Sikiric et al.   Biomedicines

Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro

(2022) Bing-Shen Huang et al.   LIFE SCIENCES

Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157

(2022) Ozren Gamulin et al.   Biomedicines

Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle

(2022) Mario Staresinic et al.   Biomedicines

Tissue sample analysis for post mortem determination of brain edema

(2021) Melanie Bauer et al.   FORENSIC SCIENCE INTERNATIONAL

Pharmacology of Drugs Used as Stimulants

(2021) James R. Docherty et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing

(2021) Sven Seiwerth et al.   Frontiers in Pharmacology

Complex Syndrome of the Complete Occlusion of the End of the Superior Mesenteric Vein, Opposed with the Stable Gastric Pentadecapeptide BPC 157 in Rats

(2021) Mario Knezevic et al.   Biomedicines

Occluded Superior Mesenteric Artery and Vein. Therapy with the Stable Gastric Pentadecapeptide BPC 157

(2021) Mario Knezevic et al.   Biomedicines

Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension

(2021) Mario Knezevic et al.   Biomedicines

BPC 157 Therapy and the Permanent Occlusion of the Superior Sagittal Sinus in Rat: Vascular Recruitment

(2021) Slaven Gojkovic et al.   Biomedicines

Robert’s Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General Peripheral and Central Syndrome, Counteracted by the Stable Gastric Pentadecapeptide BPC 157

(2021) Slaven Gojkovic et al.   Biomedicines

Physiological and Immunological Status of Adult Honeybees (Apis mellifera) Fed Sugar Syrup Supplemented with Pentadecapeptide BPC 157

(2021) Ivana Tlak Gajger et al.   Biology-Basel

BPC 157 as Potential Treatment for COVID-19

(2021) Sarah A. Deek   MEDICAL HYPOTHESES

Pentadecapeptide BPC 157 and the central nervous system

(2021) Jakša Vukojevic et al.   Neural Regeneration Research

Gastric pentadecapeptide BPC 157 in cytoprotection to resolve major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome

(2021) Predrag Sikiric et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats

(2021) Marijan Tepes et al.   Frontiers in Pharmacology

Over-Dose Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric Pentadecapeptide BPC 157

(2021) Sanja Strbe et al.   Biomedicines

Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot

(2020) Sanja Konosic et al.   Oxidative Medicine and Cellular Longevity

The association and influencing factors between antipsychotics exposure and the risk of VTE and PE: a systematic review and meta-analysis

(2020) Luqi Dai et al.   CURRENT DRUG TARGETS

BPC157 rescued NSAID-cytotoxicity via stabilizing intestinal permeability and enhancing cytoprotection

(2020) Jong Min Park et al.   CURRENT PHARMACEUTICAL DESIGN

Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds

(2020) Chuanyang Xu et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats

(2020) Jakša Vukojević et al.   Brain and Behavior

Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway

(2020) Ming-Jer Hsieh et al.   Scientific Reports

Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling ‘positive-like’ symptoms of schizophrenia

(2020) Andrea Zemba Cilic et al.   BEHAVIOURAL BRAIN RESEARCH

Clopidogrel-Induced Gastric Injury in Rats is Attenuated by Stable Gastric Pentadecapeptide BPC 157

(2020) Hailu Wu et al.   Drug Design Development and Therapy

Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation

(2019) Anita Zenko Sever et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing

(2019) Daniel Gwyer et al.   CELL AND TISSUE RESEARCH

The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation

(2019) Michela Ferrucci et al.   Frontiers in Neuroanatomy

Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats

(2019) Darko Perovic et al.   Journal of Orthopaedic Surgery and Research

Amphetamine-induced coronary artery dissection and massive aortic valve thrombus

(2019) Matthias Eberhard et al.   EUROPEAN HEART JOURNAL

Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAME

(2019) Mario Sucic et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence

(2018) Anna K. Jönsson et al.   CNS DRUGS

BPC157 as potential agent rescuing from cancer cachexia

(2018) Eun A Kang et al.   CURRENT PHARMACEUTICAL DESIGN

BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing

(2018) Sven Seiwerth et al.   CURRENT PHARMACEUTICAL DESIGN

Stable gastric pentadecapeptide BPC 157 in honeybee (Apis mellifera ) therapy, to control Nosema ceranae invasions in apiary conditions

(2018) I. Tlak Gajger et al.   JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS

Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157

(2018) Jakša Vukojević et al.   VASCULAR PHARMACOLOGY

Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes

(2018) Diogo Ramalho et al.   Revista Portuguesa de Cardiologia

Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing

(2018) Predrag Sikiric et al.   CURRENT PHARMACEUTICAL DESIGN

Cytoprotective Mechanism of the Novel Gastric Peptide BPC157 in Gastrointestinal Tract and Cultured Enteric Neurons and Glial Cells

(2018) Xi-Yu Wang et al.   Neuroscience Bulletin

Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine

(2018) Fedor Amic et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Neuroprotective Properties of Panax notoginseng Saponins via Preventing Oxidative Stress Injury in SAMP8 Mice

(2017) Jin-Lan Huang et al.   Evidence-based Complementary and Alternative Medicine

BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats

(2017) Dean Strinic et al.   LIFE SCIENCES

Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights

(2017) Antonija Duzel et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Class side effects: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine antagonists, neuroleptics, anti-emetics, l-NAME, pentadecapeptide BPC 157 and l-arginine

(2017) Zeljka Belosic Halle et al.   INFLAMMOPHARMACOLOGY

Cyclophosphamide induced stomach and duodenal lesions as a NO-system disturbance in rats: l-NAME, l-arginine, stable gastric pentadecapeptide BPC 157

(2017) Krešimir Luetic et al.   INFLAMMOPHARMACOLOGY

Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications

(2016) Predrag Sikiric et al.   Current Neuropharmacology

Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation

(2016) Ming-Jer Hsieh et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram

(2015) Ingrid Berling et al.   ANNALS OF EMERGENCY MEDICINE

Antipsychotic medication in schizophrenia: a review

(2015) John Lally et al.   BRITISH MEDICAL BULLETIN

Sudden Cardiac Death and Disorders of the QT Interval: Anesthetic Implications and Focus on Perioperative Management

(2015) Harish Ramakrishna et al.   JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA

Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro

(2015) Tonglie Huang et al.   Drug Design Development and Therapy

Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine

(2015) Mirjana Stupnisek et al.   PLoS One

Short QT Syndrome: A Predictable Story

(2014) Josep Brugada et al.   CARDIOLOGY

Stable Gastric Pentadecapeptide BPC 157-NO-system Relation

(2014) Predrag Sikiric et al.   CURRENT PHARMACEUTICAL DESIGN

Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts

(2014) Chung-Hsun Chang et al.   MOLECULES

Drug-induced QT-interval shortening following antiepileptic treatment with oral rufinamide

(2012) Rainer Schimpf et al.   HEART RHYTHM

Antipsychotic drugs and risk of pulmonary embolism

(2011) Benoit Allenet et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics

(2011) Fu De Yang et al.   PSYCHOPHARMACOLOGY

Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin

(2011) Mirjana Stupnisek et al.   THROMBOSIS RESEARCH

The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

(2010) Chung-Hsun Chang et al.   JOURNAL OF APPLIED PHYSIOLOGY

QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia

(2010) Yuji Ozeki et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The effects of the second generation antipsychotics and a typical neuroleptic on collagen-induced platelet aggregationin vitro

(2010) Anna Dietrich-Muszalska et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation

(2010) Anna Dietrich-Muszalska et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives

(2009) Rashmi R Shah   BRITISH JOURNAL OF PHARMACOLOGY

Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART I

(2009) R. Miller   Current Neuropharmacology